Diphenoxylate Hydrochloride And Atropine Sulfate Tablet
Product Images NDC 69315-910

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Diphenoxylate Hydrochloride And Atropine Sulfate (NDC 69315-910). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Leading Pharma, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemicalstructureatropine (Chemstructure 01)

Chemical structure diagram of diphenoxylate hydrochloride and atropine sulfate as shown in the product labeling for Diphenoxylate Hydrochloride and Atropine Sulfate tablets by Leading Pharma, LLC.*

FDA Label Image

Chemicalstructurediphen (Chemstructure)

Chemical structure of diphenoxylate hydrochloride, the active ingredient in Diphenoxylate Hydrochloride and Atropine Sulfate tablets by Leading Pharma, LLC.*

FDA Label Image

Container2.5-0.025mg1000cc (Container2p5 0p025mg1000cc)

Label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets, USP, 2.5 mg/0.025 mg, oral tablets. The label indicates a package size of 1000 tablets and is marked Rx only. The product is labeled by Leading Pharma, LLC, with NDC 69315-910-10. Additional information includes dosage form, active ingredient strengths, pharmacist cautions, storage instructions, and barcode.*

FDA Label Image

Container2.5-0.025mg100cc (Container2p5 0p025mg100cc)

Label for Diphenoxylate Hydrochloride and Atropine Sulfate Tablets USP, 2.5/0.025 mg, oral tablets by Leading Pharma, LLC. The label shows prescription status, package quantity of 100 tablets, and includes usage warnings and storage instructions. The NDC is 69315-910-01.*

FDA Label Image

Container2.5-0.025mg90cc (Container2p5 0p025mg90cc)

Label for Diphenoxylate Hydrochloride and Atropine Sulfate tablets, USP, 2.5/0.025 mg strength. The product is an oral tablet formulation by Leading Pharma, LLC. The package contains 90 tablets and is marked Rx only. The label includes dosage information and storage instructions, along with a barcode and manufacturer details.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.